These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

48 related articles for article (PubMed ID: 9190225)

  • 1. [The effect of modified forms of vasopressin on the rat hemostatic system].
    Grigor'eva ME; Kalishevskaia TM; Golubeva MG; Kaurov OA; Smirnova MP
    Izv Akad Nauk Ser Biol; 1997; (2):238-41. PubMed ID: 9190225
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Structure-activity determination of physiological reactions of vasopressin and its analogs on the hemostasis system].
    Golubeva MG; Kalishevskaia TM; Solov'eva ME
    Vopr Med Khim; 1992; 38(1):42-4. PubMed ID: 1441293
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effect of vasopressin and its analogs on blood coagulation in rats].
    Golubeva MG; Kalishevskaia TM; Solov'eva ME
    Fiziol Zh (1978); 1990; 36(3):25-30. PubMed ID: 2394244
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hydroosmotic activities of arginine-vasopressins modified either in positions 1, 2 and 4 or at N-terminal extensions.
    Bakos P; Shakhmatova EI; Ponec J; Alexandrová M; Lichardus B; Lammek B; Rekowski P; Kupryszewski G
    Gen Physiol Biophys; 1992 Aug; 11(4):359-76. PubMed ID: 1426981
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The role of cholinergic receptors in the reactions of the hemostasis system to vasopressin].
    Kalishevskaia TM; Golubeva MG; Solo'veva ME
    Fiziol Zh (1978); 1989; 35(5):9-14. PubMed ID: 2591588
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Suppression of natriferic activity of the vasopressin molecule by modifications in positions 1, 2 and 4.
    Bakos P; Ponec J; Alexandrová M; Lichardus B; Lammek B; Rekowski P; Kupryszewski G
    Gen Physiol Biophys; 1990 Dec; 9(6):605-13. PubMed ID: 2079200
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analogs of arginine vasopressin modified in the N-terminal part of the molecule with a conformationally constrained cis-peptide bond motif.
    Sobolewski D; Prahl A; Derdowska I; Slaninová J; Kaczmarek K; Zabrocki J; Lammek B
    J Pept Sci; 2007 Feb; 13(2):128-32. PubMed ID: 17146804
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of physiological concentrations of vasopressin on haemostatic function in man.
    Grant PJ; Davies JA; Tate GM; Boothby M; Prentice CR
    Clin Sci (Lond); 1985 Oct; 69(4):471-6. PubMed ID: 3930128
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of interactions responsible for vasopressin binding to human neurohypophyseal hormone receptors-molecular dynamics study of the activated receptor-vasopressin-G(alpha) systems.
    Slusarz MJ; Giełdoń A; Slusarz R; Ciarkowski J
    J Pept Sci; 2006 Mar; 12(3):180-9. PubMed ID: 16114100
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of vasopressin mediated effects on hemostatic mechanisms: relationship with aquaporins and caveolin proteins.
    Tyagi MG; Namboodri KV
    Indian J Exp Biol; 2005 Aug; 43(8):710-4. PubMed ID: 16121712
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An exploration of the effects of L- and D-tetrahydroisoquinoline-3-carboxylic acid substitutions at positions 2, 3 and 7 in cyclic and linear antagonists of vasopressin and oxytocin and at position 3 in arginine vasopressin.
    Manning M; Cheng LL; Stoev S; Bankowski K; Przybyiski J; Klis WA; Sawyer WH; Wo NC; Chan WY
    J Pept Sci; 1995; 1(1):66-79. PubMed ID: 9222985
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vasopressin-induced intracellular Ca²⁺ concentration responses in non-neuronal cells of the rat dorsal root ganglion.
    Moriya T; Kayano T; Kitamura N; Hosaka YZ; Asano A; Forostyak O; Verkhratsky A; Viero C; Dayanithi G; Toescu EC; Shibuya I
    Brain Res; 2012 Nov; 1483():1-12. PubMed ID: 22975133
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vasopressin antidiuretic agonist and antagonist activity in dogs: structural and stereochemical relationship between bridge and carboxyl terminus.
    Albrightson-Winslow CR; Brickson B; Brooks DP; Bryan WM; Caldwell N; Kinter LB; Moore ML; Nambi P; Stassen FL; Huffman WF
    J Pharmacol Exp Ther; 1991 Jan; 256(1):335-40. PubMed ID: 1988664
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Arginine vasopressin (AVP) replacement of helper cell requirement in IFN-gamma production. Evidence for a novel AVP receptor on mouse lymphocytes.
    Torres BA; Johnson HM
    J Immunol; 1988 Apr; 140(7):2179-83. PubMed ID: 2965181
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro degradation of some arginine-vasopressin analogs by homogenates of rat kidney, liver and serum.
    Grzonka Z; Kasprzykowski F; Lubkowska L; Darłak K; Hahn TA; Spatola AF
    Pept Res; 1991; 4(5):270-4. PubMed ID: 1802238
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of endothelin and vasopressin in DOCA-salt hypertension.
    Yu M; Gopalakrishnan V; McNeill JR
    Br J Pharmacol; 2001 Apr; 132(7):1447-54. PubMed ID: 11264238
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacological characterization of FE 202158, a novel, potent, selective, and short-acting peptidic vasopressin V1a receptor full agonist for the treatment of vasodilatory hypotension.
    Laporte R; Kohan A; Heitzmann J; Wisniewska H; Toy J; La E; Tariga H; Alagarsamy S; Ly B; Dykert J; Qi S; Wisniewski K; Galyean R; Croston G; Schteingart CD; Rivière PJ
    J Pharmacol Exp Ther; 2011 Jun; 337(3):786-96. PubMed ID: 21411496
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structure activity relationship studies with C-terminal fragments of vasopressin and oxytocin on avoidance behaviors of rats.
    de Wied D; Gaffori O; Burbach JP; Kovács GL; van Ree JM
    J Pharmacol Exp Ther; 1987 Apr; 241(1):268-74. PubMed ID: 3572787
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vasopressin and vasopressin-antagonists applied to neonatal Wistar rats: effects on body and brain development and water metabolism.
    Snijdewint FG; Boer GJ
    Neurobehav Toxicol Teratol; 1986; 8(3):213-7. PubMed ID: 3736748
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Memory effects of arginine vasopressin (AVP) and [7-9] fragment of its peptide chain in rats.
    Klimkiewicz T
    Acta Neurobiol Exp (Wars); 2001; 61(4):267-76. PubMed ID: 11905148
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.